Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis
ObjectiveCentral glucagon-like peptide-1 (GLP-1) is a target in treating obesity due to its effect on suppressing appetite, but the possible downstream key genes that GLP-1 regulated have not been studied in depth. This study intends to screen out the downstream feeding regulation genes of central G...
Main Authors: | Yuwei Shao, Jun Tian, Yanan Yang, Yan Hu, Ye Zhu, Qing Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.931161/full |
Similar Items
-
Evaluation the activity of Neuropeptide Y (NPY), Glucagon like peptide-1 and Ghrelin in controlling appetite in obesity in Erbil City
by: Sawen Tahseen Taha ,Leweza Belal Abbas
Published: (2023-02-01) -
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01) -
Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
by: A. Delgado, et al.
Published: (2021-04-01) -
Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
by: Jens Juul Holst
Published: (2022-08-01) -
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
by: Alorfi NM, et al.
Published: (2022-08-01)